These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa. Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598 [TBL] [Abstract][Full Text] [Related]
5. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738 [TBL] [Abstract][Full Text] [Related]
6. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053 [TBL] [Abstract][Full Text] [Related]
7. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator. Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620 [TBL] [Abstract][Full Text] [Related]
8. Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Cao B; Mijiti X; Deng LL; Wang Q; Yu JJ; Anwaierjiang A; Qian C; Li M; Fang DA; Jiang Y; Zhao LL; Zhao X; Wan K; Liu H; Li G; Yuan X Infect Drug Resist; 2023; 16():3117-3135. PubMed ID: 37228658 [TBL] [Abstract][Full Text] [Related]
9. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis. Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006 [TBL] [Abstract][Full Text] [Related]
10. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528 [TBL] [Abstract][Full Text] [Related]
11. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337 [TBL] [Abstract][Full Text] [Related]
12. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities. Vilchèze C; Jacobs WR Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204 [TBL] [Abstract][Full Text] [Related]
13. EthA/R-Independent Killing of Ang MLT; Zainul Rahim SZ; de Sessions PF; Lin W; Koh V; Pethe K; Hibberd ML; Alonso S Front Microbiol; 2017; 8():710. PubMed ID: 28487681 [TBL] [Abstract][Full Text] [Related]
14. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis. Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218 [TBL] [Abstract][Full Text] [Related]
15. Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand. Boonaiam S; Chaiprasert A; Prammananan T; Leechawengwongs M Clin Microbiol Infect; 2010 Apr; 16(4):396-9. PubMed ID: 19486070 [TBL] [Abstract][Full Text] [Related]
16. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis]. Rueda J; Realpe T; Mejía G; Zapata E; Robledo J Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443 [TBL] [Abstract][Full Text] [Related]
17. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations. Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241 [TBL] [Abstract][Full Text] [Related]
18. Mutation in Eth A protein of Mycobacterium tuberculosis conferred drug tolerance against enthinoamide in Mycobacterium smegmatis mc Anand PK; Kumar A; Saini A; Kaur J Comput Biol Chem; 2022 Jun; 98():107677. PubMed ID: 35397466 [TBL] [Abstract][Full Text] [Related]
19. Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis. Hicks ND; Carey AF; Yang J; Zhao Y; Fortune SM mBio; 2019 Apr; 10(2):. PubMed ID: 31015328 [TBL] [Abstract][Full Text] [Related]
20. Can inhA mutation predict ethionamide resistance? Vadwai V; Ajbani K; Jose M; Vineeth VP; Nikam C; Deshmukh M; Shetty A; Soman R; Rodrigues C Int J Tuberc Lung Dis; 2013 Jan; 17(1):129-30. PubMed ID: 23146620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]